急性住院期间进入临终关怀或接受姑息治疗咨询与后续抗生素使用的关联
这项回顾性队列研究纳入2014年1月1日至2019年12月31日死亡的全国退伍军人事务部患者,采用倾向评分匹配比较临终关怀或姑息治疗与对照组的抗生素使用。临终关怀组匹配9808对,姑息治疗组匹配40796对;安置或咨询后14天内,临终关怀组41%和姑息治疗组48%接受至少一种抗生素,对照组分别为25%和27%。进入临终关怀与抗生素处方绝对增加12%独立相关,进入姑息治疗与绝对增加17%相关。
要点
- 临终关怀组安置后14天内41%(4040/9808)接受至少一种抗生素,匹配非临终关怀组为25%(2420/9808)。
- 姑息治疗组咨询后14天内48%(19735/40796)接受至少一种抗生素,匹配非姑息治疗组为27%(10991/40796)。
- 进入临终关怀与抗生素处方绝对增加12%独立相关,进入姑息治疗与绝对增加17%相关。
核心结论
- 在该退伍军人事务部人群中,接受临终关怀的患者抗生素暴露水平高,尤其在接受临终关怀或姑息治疗咨询的住院期间。
研究设计与样本
- 回顾性队列研究,纳入2014年1月1日至2019年12月31日死亡的全国退伍军人事务部患者,且死亡前6个月内曾住院。
- 收集退伍军人事务部整合电子病历数据,包括人口学、合并症、住院抗生素使用时长及门诊抗生素发放。
- 采用倾向评分匹配队列分析,比较进入临终关怀或接受姑息治疗的住院患者与未接受相应处理的住院患者。
- 临终关怀组匹配9808对患者,姑息治疗组匹配40796对患者。
主要发现
- 安置或咨询后14天内,临终关怀组41%(4040/9808)接受至少一种抗生素,匹配非临终关怀组为25%(2420/9808)。
- 咨询后14天内,姑息治疗组48%(19735/40796)接受至少一种抗生素,匹配非姑息治疗组为27%(10991/40796)。
- 进入临终关怀与抗生素处方绝对增加12%独立相关。
- 进入姑息治疗与抗生素处方绝对增加17%相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to estimate antibiotic use during the last 6 months of life for hospitalized patients under hospice or palliative care and identify potential targets (i.e. time points) for antibiotic stewardship during the end-of-life period. METHODS: We conducted a retrospective cohort study of nationwide Veterans Affairs (VA) patients who died between January 1, 2014 and December 31, 2019 and who had been hospitalized within 6 months prior to death. Data from the VA's integrated electronic medical record were collected, including demographics, comorbid conditions, and duration of inpatient antibiotics administered, along with outpatient antibiotics dispensed. A propensity score-matched cohort analysis was conducted to compare antibiotic use between hospitalized patients placed into palliative care or hospice matched to hospitalized patients not receiving palliative care or hospice. RESULTS: There were 9808 and 40 796 propensity score-matched patient pairs in the hospice and palliative care groups, respectively. Within 14 days of placement or consultation, 41% (4040/9808) of hospice patients and 48% (19 735/40 796) of palliative care patients received at least one antibiotic, while 25% (2420/9808) matched nonhospice and 27% (10 991/40 796) matched nonpalliative care patients received antibiotics. Entry into hospice was independently associated with a 12% absolute increase in antibiotic prescribing, and entry into palliative care was associated with a 17% absolute increase during the 14 days post-entry vs. pre-entry period. DISCUSSION: We observed that patients receiving end-of-life care had high levels of antibiotic exposure across this VA population, particularly during admissions when they received hospice or palliative care consultation.
引用
- Marra AR, Clore GS, Balkenende E, et al. Association of entry into hospice or palliative care consultation during acute care hospitalization with subsequent antibiotic utilization. Clin Microbiol Infect. 2022. PMID: 35931374. doi:10.1016/j.cmi.2022.07.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。